RE: RE: "too bad about the SP" The Conf Call and MD&A are classic McRae pieces....without doubt.
Disappointing on many levels, but our cash will keep up afloat until the other items start the much needed cash injection. The Q1 numbers will be most telling and important on where our short-term numbers go from here.....
But that said, I still assert that McRae will not stand in front of the angry mob at the AGM without some carrot to keep the masses at bay......simply saying he shtcanned a bunch of top feeders won't do it and he knows it.....
The MD&A makes multiple mention of preclinical work being completed on some MCC indications...I suspect a new trial with either Endo or newbie lighting up before end of calendar year.....